Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ChargePoint Technology has made two appointments to reinforce its presence in aseptic manufacturing and increase its presence in France and the Benelux region.
read more
LSNE continues their expansion with the addition of increased cGMP storage capabilities at its 7 Commerce Drive facility located in Bedford, New Hampshire.
read more
Cambrex announced it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland, doubling the current footprint to 15,000 sq. ft.
read more
Samsung BioLogics and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive supranuclear palsy.
read more
Lonza and Vineti announced a partnership in the cell and gene therapy field and across Lonza's 'vein-to-vein' delivery network.
read more
Caprion Biosciences and HistoGeneX have agreed to combine their respective businesses.
read more
The FDA and the EMA are publishing the discussion and main conclusions from a workshop held on November 26, 2018, at the EMA headquarters in London.
read more
Thursday, August 01, 2019
FUJIFILM has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark from Biogen.
read more
Thursday, August 01, 2019
Marken has announced the acquisition of PCX International based in Japan.
read more
Thursday, August 01, 2019
Exelixis has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited.
read more
Thursday, August 01, 2019
GVK BIO and BE Pharmaceuticals announced a strategic collaboration in drug product development.
read more
Pfizer announced the closing of its joint venture with GlaxoSmithKline to combine and create the world’s largest OTC business.
read more
Omeros and Lonza announced a long-term manufacturing agreement for commercial production of narsoplimab, also referred to as OMS721.
read more
Amneal announced its Co-Founders, Chirag Patel and Chintu Patel, have been named Co-Chief Executive Officers, effective immediately.
read more
CordenPharma Group announced the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective August 1, 2019.
read more